HFpEF and AF - catheter ablation should be preferred for rhythm control over antiarrhythmic drugs: rebuttal & discussion

17 April 2023 (17:05 - 17:15)

Organised by:

Video

Sign in for access options

5 More presentations in this session

Presentation thumbnail

HFpEF and AF - catheter ablation should be preferred for rhythm control over antiarrhythmic drugs: protagonist

Professor L. Di Biase (The Bronx, US)

Presentation thumbnail

HFpEF and AF - catheter ablation should be preferred for rhythm control over antiarrhythmic drugs: antagonist

Professor P. Kirchhof (Hamburg, DE)

Presentation thumbnail

Pulsed field ablation should be preferred over thermal ablation in catheter ablation of AF: protagonist

Professor P. Jais (Neuilly sur Seine, FR)

Presentation thumbnail

Pulsed field ablation should be preferred over thermal ablation in catheter ablation of AF: antagonist

Professor D. Shah (Geneva, CH)

Presentation thumbnail

Pulsed field ablation should be preferred over thermal ablation in catheter ablation of AF: rebuttal & discussion

Access the full session

Session thumbnail

Controversial debates in AF ablation (I)

The Event

Event poster

EHRA 2023

17 April 2023 17:05 CET

You may be interested in

Congress Session

Great Debate: atrial fibrillation and heart failure - 'to ablate or not to ablate, that is the question'

Congress Presentation

First-line atrial fibrillation ablation should be offered to all patients with atrial fibrillation and heart failure with reduced ejection fraction (HFrEF) - discussion

Congress Presentation

Atrial fibrillation ablation should be more widely used in heart failure - discussion

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources